Mycobacterium abscessus was isolated from cultures of seven blood samples from a 64-year-old diabetic female who was admitted due to steroid-unresponsive adrenal insufficiency. The isolates were difficult to identify using the conventional commercial systems, VITEK 2 (bioMérieux, France) or MicroScan (Siemens Healthcare Diagnostics, USA), but were rapidly identified as M. abscessus by a matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-based Bruker Biotyper system (Bruker Daltonics, USA). Identification of M. abscessus was confirmed by a reverse hybridizationbased assay (Genotype Mycobacterium CM/AS 12, Hain Lifescience) and direct sequencing of a heatshock protein gene. After removal of her central venous catheter, the patient was successfully treated with a combination therapy comprising clarithromycin, amikacin, cefoxitin, and imipenem. Our findings demonstrate that MALDI-TOF MS can facilitate rapid and accurate identification of M. abscessus from blood cultures, which enables prompt administration of appropriate therapy following catheter removal. 
INTRODUCTION
Mycobacterium abscessus comprises a group of rapidly growing (within 7 days on solid media), multidrug-resistant, nontuberculous mycobacteria (NTM) species that are ubiquitous in soil and water [1] . M. abscessus causes pulmonary and skin and soft-tissue infections [2, 3] . Although M. abscessus bacteremia is rare in Korea, the number of M. abscessus bacteremia cases reported worldwide has increased [3] [4] [5] . Correct identification of M. abscessus has clinical relevance, especially because there are closely related species, M. massiliense and M. bolletii, which showed different susceptibility to clarithromycin, and their pathogenic potentials [6] . However, diagnosis of M. abscessus bacteremia can be challenging, because identification of this rapidly growing NTM using conventional identification systems is problematic [5] . Recently, the introduction of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) provides a rapid identification for clinical isolates of NTM. The identification ability of MALDI-TOF MS for NTM has been assessed and improved by several studies in various setting of the composition of database, or sample pretreatment [7, 8] . Here, we report a rare case of M. abscessus bacteremia in which blood isolates were identified by MALDI-TOF MS. The findings demonstrate that MALDI-TOF MS can facilitate diagnosis of M. abscessus bacteremia.
CASE REPORT
A 64-year-old female suffering from adrenal insufficiency was transferred to our hospital because of non-responsiveness to steroid replacement therapy. She had a history of hypertension, diabetes mellitus, and hypoglycemic encephalopathy. On admis- Fig. 1 ). Antibiotic therapy with cefazolin was started on the day of admission; on day 6, this therapy was changed to ertapenem and teicoplanin, and, on day 10, it was changed to a combination of clarithromycin, amikacin, cefoxitin, and imipenem.
The CVC was removed on day 6, and a culture of the catheter tip yielded no growth. The patient suffered from intermittent fever (temperature, 37.4-39.3 o C) from the day of admission, but this gradually subsided and blood cultures became negative on day 10. The patient's condition improved and she was discharged from the hospital on day 20. (Fig. 2) . The bacteria produced catalase.
The isolates were identified as Kocuria rosea (94% probability) using VITEK 2 with a GP card (bioMérieux, Marcy-l'Étoile, France) and as Micrococcus and related species using MicroScan (Fig. 3) . Antimicrobial susceptibility testing at the Korean Institute of Tuberculosis [10] indicated that the isolate exhibited inducible resistance to clarithromycin (MIC, 2 μg/mL and ＞64 μg/mL); resistance to ciprofloxacin (＞16 μg/mL), doxycycline (＞32 μg/mL), and moxifloxacin (8 μg/mL); and intermediate resistance to amikacin (＞32 μg/mL), cefoxitin (＞32 μg/mL), and imipenem (8 μg/mL).
DISCUSSION
To date, about 20 species of rapidly growing NTM that are capable of causing bloodstream infections have been identified [5] . However, reports of cases of bloodstream infections by rapidly growing NTM have been limited [4, 5] which may reflect, in part, the difficulty in identifying this species from blood cultures. M. abscessus isolates recovered from blood cultures could be regarded as skin contaminants or misidentified as Corynebacterium spp., because they are Gram-positive, nonmotile, and catalase-positive bacilli. In the present study, the isolates were misidentified by VITEK 2 with a GP card and Microscan, but they were correctly identified as M. abscessus by MALDI-TOF MS. The identification of M. abscessus was supported by a positive AFB stain result. Our case highlighted that MALDI-TOF MS can be considered as a rapid diagnostic tool of bacteremia caused by rapid growing NTM including M.
abscessus.
Recent studies have shown that M. abscessus and other mycobacterial species can be identified by MALDI-TOF MS [7, 8, 11, 12] . In study which compares MALDI-TOF MS and reverse hybridization-based assay for the identification of NTM, the concordance analysis between the two methods showed agreement in 96.9% [7] . However, these studies utilized colonies grown on Lowenstein medium or Middlebrook 7H11 agar, which are used for mycobacterial culture, because most isolates were from respiratory specimens. The present study showed that 
